Home/BioArdis/Frank Kayser, Ph.D.
FK

Frank Kayser, Ph.D.

Chief Scientific Officer, Small Molecule

BioArdis

BioArdis Pipeline

DrugIndicationPhase
FGFR4 InhibitorHepatocellular Carcinoma (HCC) & other cancersPre-clinical
CD73 InhibitorOncology (Tumor Microenvironment Modulation)Pre-clinical
Undisclosed Oncology ProgramOncologyPre-clinical
Dermatological TherapyUndisclosed Dermatological ConditionLead Optimization
CAR-T TherapiesSolid TumorsIND-enabling